11+ hour, 36+ min ago  (1112+ words) Guest Column | June 26, 2026 A conversation between Helus Pharma Chief Medical Officer Amir Inamdar, MBBS, DNB (Psych), MFPM, and Clinical Leader Executive Editor Abby Proch As psychedelic therapies move into late-stage development, trial design decisions take on heightened importance " particularly in…...